WEDNESDAY, June 4, 2025 (HealthDay News) — Pepto Bismol is a go-to stomach remedy, but a new study suggests it might not help prevent diarrhea during international travel. The study, led by the U.S. Centers for Disease Control and Prevention (CDC), found that people who took bismuth subsalicylate — theContinue Reading
New vaccine represents a step forward in development of next-generation coronavirus vaccinesContinue Reading
TUESDAY, June 3, 2025 (HealthDay News) — Americans planning to travel outside the country should make sure they’re vaccinated against measles — no matter where they’re headed, U.S. health officials say. The U.S. Centers for Disease Control and Prevention (CDC) updated its guidance last week to recommend measles-mumps-rubella (MMR) shotsContinue Reading
TUESDAY, June 3, 2025 (HealthDay News) — Declining vaccination rates are making more and more U.S. children vulnerable to measles and mumps, a new study says. A national decrease in MMR (measles/mumps/rubella) vaccinations among American children has occurred since the start of the COVID-19 pandemic, researchers reported June 2 inContinue Reading
Tryptyr works by stimulating corneal sensory nerves to increase natural tear productionContinue Reading
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and olderContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — Pod-style e-cigarettes appear to be more addictive than nicotine gum, making it harder for vapers to kick the habit, a small-scale lab study has found. E-cigarettes reinforced nicotine addiction more than nicotine gum among young adults who regularly vape, results show. Specifically, theContinue Reading
THURSDAY, May 22, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies toContinue Reading
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapyContinue Reading
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall. The new framework, announced Tuesday, says adults 65 and older, and people with certain health conditions, canContinue Reading